CHRNG-associated hypo-akinesia disorder of prenatal onset
Go to external page http://purl.obolibrary.org/obo/MONDO_0100158
A spectrum of presentations resulting from biallelic protein-altering variation in CHRNG. Inactivation of the receptor during early development leads to prenatal hypo-akinesia; subsequent phenotypes are a consequence of this hypo-akinesia and are thought to be dependent upon timing and severity of the anomaly at the neuromuscular junction. A range of phenotypes varying in severity (including both lethal and non-lethal presentations) have been reported, but typically include joint contractures, pterygia, dysmorphic features, vertebral and thoracic anomalies, and additional variable abnormalities. There are no clear genotype-phenotype correlations between the lethal and non-lethal presentations of this spectrum; both inter- and intra-familial variability have been reported, with the same variants being observed in both lethal and non-lethal cases. [ http://www.ncbi.nlm.nih.gov/pubmed/22167768 http://www.ncbi.nlm.nih.gov/pubmed/16826531 http://www.ncbi.nlm.nih.gov/pubmed/30868735 https://www.clinicalgenome.org/affiliation/40106/ http://www.ncbi.nlm.nih.gov/pubmed/16826520 ]
Synonyms: CHRNG-associated hypo-akinesia disorder of prenatal onset
Term information
rare, inferred_rare, clingen
This term encompasses both autosomal recessive multiple pterygium syndrome and lethal multiple pterygium syndrome but is not the only possible cause of either of these presentations.